Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on BridgeBio Pharma Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2023230560A1 | Application | Treatment of organic acidemias or pantothenate kinase associated neurodegeneration with modulators of pantothenate kinases | November 30, 2023 | |
| WO2023225252A1 | Application | Compositions and methods for inhibition of ras | A61P35/00; C07D471/04 | November 23, 2023 |
| IL307361A | Application | 6-(4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(2,3-dichlorophenyl)-2-methylpyrimidin-4(3h)-one derivatives and related compounds as ptpn11 (shp2) inhibitors for treating cancer | A61K31/506; A61P35/00; C07D401/04; C07D471/04; C07D491/10; C07D491/107 | November 01, 2023 |
| WO2023205794A1 | Application | Combination therapy using a pyrimidone derivative as ptpn11 inhibitor and a pd-1/pd-l1 inhibitor and its use in the treatment of cancer | A61K2039/505; A61K2039/545; A61K31/506; A61K39/3955; A61K45/00; A61P35/00; C07K16/2818; C07K16/2827; C07K2317/524; C07K2317/71; C07K2317/73 | October 26, 2023 |
| WO2023205795A1 | Application | Combination therapy using a substituted pyrimidin-4(3H)-one and nivolumab as well as its use in the treatment of cancer | A61K2039/505; A61K2039/545; A61K31/506; A61P35/00; C07K16/2818; C07K2317/21; C07K2317/71 | October 26, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer